bonedaddy77

Married father of two. Have a day job and just trade on the side. Anything I post is my opinion. Just trying to make a buck and happy if others can too.

[bonedaddy77 @bonedaddy77]

@lambrecht2 Id be happy to see any kind of filing.

[bonedaddy77 @bonedaddy77]

$STEV .0038 seeing a lot of accumulation down here in the .003-.004 range. Something is up.

[bonedaddy77 @bonedaddy77]

@lambrecht2 I think he was basically just babysitting the company while trying to make some deals. Those deals fell through and now just waiting. Share structure is still solid…eventually a reverse merger candidate will appear IMO

[Rigatoni @rigatoni33]

$SPEV .23...

Now that this shell is filled with a top-notch CEO in Paul Mann who recently rang the bell on the NASDAQ for ASPI, I expect to blow through the previous highs on this long term chart. The float remains small...

Added my last block just now>

[bonedaddy77 @bonedaddy77]

@lambrecht2 Still hoping we see something one day. Been a long long time

[Rigatoni @rigatoni33]

$SPEV .14...

You may be interested to know,

My last piece to the current roadmap so you know who is running this new company moved into SPEV. I mentioned he was the CEO of ASPI and posted his resume that is attached.

Look where he was today...
https://t.co/0J06J0jIDO

*About This Event*
ASP Isotopes (Nasdaq: ASPI), a development-stage advanced materials company building a differentiated isotope enrichment platform to enhance global supply chain access to critical materials for nuclear medicine, next-generation semiconductors, and nuclear energy, visits the Nasdaq MarketSite in Times Square.

In honor of the occasion, Paul Mann, Founder, CEO and Chairman, rings the opening bell.

[Rigatoni @rigatoni33]

$SPEV .12 News...

Last of the cheapies today imo ...

Shorepower Technologies (OTC: SPEV) Enters Merger Agreement with Aeternum Health LLC and Announces Strategic Transition to Longevity-Focused Healthcare Platform

https://t.co/94c5W4WB0k

[Rigatoni @rigatoni33]

$SPEV .15...

May want to know who is behind this company,

Paul E. Mann , age 49, has, since September 2021, served as Chairman of the Board of Directors and Chief Executive Officer of ASP Isotopes Inc. (“ASP”) (Nasdaq:ASPI), a company that he co-founded in September 2021, and until September 2022 also served as its Chief Financial Officer.

From April 2020 to April 2022, he was responsible for healthcare investments at DSAM Partners LLC, a global hedge fund and from June 2018 until April 2020,
Mr. Mann was Chief Financial Officer of PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company.

From July 2016 to June 2018, he was a portfolio manager at Highbridge Capital where he managed investments in healthcare and biotechnology.

From August 2013 to March 2016,

Mr. Mann worked at Soros Fund Management where he was responsible for billions of dollars of investments in healthcare and chemicals companies. During his career as a healthcare and chemicals investor,

Mr. Mann has helped create and fund numerous early stage and start-up companies. Prior to moving to the buy-side, Mr. Mann spent 11 years as a sell-side analyst at Morgan Stanley and Deutsche Bank. He co-managed the healthcare research team at Morgan Stanley, one of the top ranked teams in Institutional Investor, Greenwich and Reuters.

He was also corporate broker to over half the UK Pharmaceutical Companies. Mr. Mann started his career as a research scientist at Procter and Gamble, and he is named as the inventor of numerous skin creams in the Oil of Olay range of cosmetics.

Between 2000 and 2023 Mr. Mann was a nonexecutive, independent director at Abeona Therapeutics (Nasdaq: ABEO), where he was the chair of the audit committee, and he is currently a director at Healthtech Solution Inc. (OTC: HLTT), where he is chairman of the board and serves on the audit committee.

He was the co-founder and Chairman of Varian Biopharma, a private biotechnology company focused on precision oncology until its sale in 2023. Mr. Mann has an MA (Cantab) and an MEng from Cambridge University, UK where he studied Natural Sciences and Chemical Engineering, and he is a CFA charter holder.

[KicksFinder @KicksFinder]

Ad: Enjoy 40% OFF using code HL25 at checkout via CNCPTS
Nike Air Max Uptempo '95 "Orlando Magic"
$102 (Retail Price: $170)

>> https://t.co/gBKCYOJ7nR

[bonedaddy77 @bonedaddy77]

@Tooockygt3 @SneakerVisionz That blows. Figured it was too good to be true.

[bonedaddy77 @bonedaddy77]

@lambrecht2 A bunch of filings just hit as company is getting current. Maybe something brewing

[bonedaddy77 @bonedaddy77]

@lambrecht2 Not sure but feels like someone has been quietly loading a ton

[bonedaddy77 @bonedaddy77]

@lambrecht2 Sure would be nice to hear something. Been way to long

[bonedaddy77 @bonedaddy77]

@lambrecht2 I don’t even watch the day to day activity anymore. Just patiently waiting

[KicksFinder @KicksFinder]

Ad: Do you own a pair of On Running? Available via DSG
W On Cloudnova Form 2 "White/Ivory"
FREE shipping

>> https://t.co/cJtcDXRGn6

[bonedaddy77 @bonedaddy77]

@martinonyc I believe Mets want him but hard to justify the money when factoring the luxury tax consequences. 50% penalty can shoot up a $25 million contract close to $37 million.

[bonedaddy77 @bonedaddy77]

@lambrecht2 Dogecoin and Litecoin is more profitable for crypto miners than Bitcoin. Maybe something with a mining firm rolling in?

[bonedaddy77 @bonedaddy77]

$STEV .0037 seeing some higher than normal volume lately. Something brewing?

[bonedaddy77 @bonedaddy77]

$STEV .004 getting smacked. Looking good here.

[bonedaddy77 @bonedaddy77]

@lambrecht2 Have no clue…just waiting on updates